FilingReader Intelligence
Sudarshan Pharma to raise up to INR 1500 crores
July 17, 2025 at 09:51 AM UTC•By FilingReader AI
Sudarshan Pharma Industries Limited plans to raise up to INR 1500 crores through issuing equity shares, Global Depository Receipts, Foreign Currency Convertible Bonds, or other convertible securities via private placements or qualified institutional placements.
The funds will be used for capital expenditure, company acquisitions, and issue expenses. Securities will be listed on Indian stock exchanges, with GDRs potentially listed internationally.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:SUDARSHAN•Bombay Stock Exchange
News Alerts
Get instant email alerts when SUDARSHAN PHARMA INDUSTRIES publishes news
Free account required • Unsubscribe anytime